VIRxSYS
A company developing gene and vaccine therapies to treat HIV/AIDS, cancer and genetic diseases
2
Funding Rounds
$50.0m
Money raised
Overview
A company developing gene and vaccine therapies to treat HIV/AIDS, cancer and genetic diseases
- Website:
Funding
Funding series
Funding Series Analysis
The company VIRxSYS has raised a total of $50m in funding over 2 rounds.
Key Insights:
- VIRxSYS funding round, December 2006: $20m
- VIRxSYS Series F round: $30m
VIRxSYS funding round, December 2006
$20m
VIRxSYS Series F round
$30m
Industries
VIRxSYS is active in the following industries: